Europe Migraine Epidemiology and Patient Flow Report 2018: Prevalence, Diagnosis Rate & Treatment Rate 2017-2026 - ResearchAndMarkets.com

DUBLIN--()--The "Europe Migraine Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

The research provides insights into Migraine epidemiology, Migraine diagnosed patients, and Migraine treatment rate for EU5 countries. The research measures key indicators including prevalence of Migraine derived from epidemiological analysis, patients diagnosed with Migraine, and patients treated with a drug therapy.

The research study helps executives estimate Migraine market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Migraine prevalence, Migraine diagnosis rate, and Migraine treatment rate for the period 2017 - 2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Topics Covered:

1. Migraine: Disease Definition

2. Migraine Patient Flow in Europe

3. Migraine Patient Flow in Germany

4. Migraine Patient Flow in France

5. Migraine Patient Flow in Spain

6. Migraine Patient Flow in Italy

7. Migraine Patient Flow in UK

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/trdqlf/europe_migraine?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs , Analgesics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs , Analgesics